跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Olmesartan/HCT Sandoz 40/25 olmesartan medoxomil/hydrochlorothiazide 40/25 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
Olmesartan/HCT Sandoz 40/25 olmesartan medoxomil/hydrochlorothiazide 40/25 mg film-coated tablet blister pack
Approved
STANDARD
Olmesartan/HCT Sandoz 40/25 olmesartan medoxomil/hydrochlorothiazide 40/25 mg film-coated tablet blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
dfae0c44e0eb8d23
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
dfae0c44e0eb8d23
Product Name
Olmesartan/HCT Sandoz 40/25 olmesartan medoxomil/hydrochlorothiazide 40/25 mg film-coated tablet blister pack
Artg Id
221130
Artg Name
Olmesartan/HCT Sandoz 40/25 olmesartan medoxomil/hydrochlorothiazide 40/25 mg film-coated tablet blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2015-02-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-01113-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02347-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
dfae0c44e0eb8d23
Type
Standard
Back to TGA Approvals